NCT04872556 2024-02-08
Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients
Chang Gung Memorial Hospital
Phase NA Terminated
Clinical Trials
17 trialsNCT03441139 2021-10-19
CRYO
Centre Leon Berard
Phase NA Terminated
NCT04040140 2021-08-13
Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain
Johns Hopkins University
Phase NA Terminated
NCT01964378 2021-07-15
CORAL
Tris Pharma, Inc.
Phase 3 Terminated
NCT00981578 2020-03-11
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
InSightec
Phase NA Terminated
NCT00140894 2019-09-20
A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 4 Terminated
NCT02078089 2017-01-31
Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
Indiana University
Phase 1 Terminated
NCT00352664 2016-05-09
The Effect of Donepezil on Sedation and Other Symptoms
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00634010 2016-05-09
Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01931865 2015-12-31
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Yale University
Phase 2 Terminated
NCT01846429 2015-06-04
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Terminated
NCT01384292 2015-06-01
Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
AstraZeneca
Phase 3 Terminated
NCT00046709 2013-10-10
Marijuana for Cancer Pain
Center for Medicinal Cannabis Research
Phase 1/2 Terminated
NCT01350583 2013-08-14
Bicarbonate for Tumor Related Pain
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Terminated
NCT00803283 2013-08-12
A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain
Johnson & Johnson Taiwan Ltd
Phase 3 Terminated
NCT00684242 2013-01-28
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00126789 2012-06-05
Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
ZARS Pharma Inc.
Phase 3 Terminated